- Home
- GENC vs OBIO Comparison
GENC vs OBIO Comparison
Compare GENC & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENC
- OBIO
- Stock Information
- Founded
- GENC 1894
- OBIO 2017
- Country
- GENC United States
- OBIO United States
- Employees
- GENC N/A
- OBIO N/A
- Industry
- GENC Construction/Ag Equipment/Trucks
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- GENC Industrials
- OBIO Health Care
- Exchange
- GENC Nasdaq
- OBIO Nasdaq
- Market Cap
- GENC 181.9M
- OBIO 151.3M
- IPO Year
- GENC N/A
- OBIO N/A
- Fundamental
- Price
- GENC $11.54
- OBIO $2.85
- Analyst Decision
- GENC
- OBIO Strong Buy
- Analyst Count
- GENC 0
- OBIO 5
- Target Price
- GENC N/A
- OBIO $15.00
- AVG Volume (30 Days)
- GENC 32.1K
- OBIO 69.1K
- Earning Date
- GENC 05-09-2025
- OBIO 05-12-2025
- Dividend Yield
- GENC N/A
- OBIO N/A
- EPS Growth
- GENC 35.02
- OBIO N/A
- EPS
- GENC 1.11
- OBIO N/A
- Revenue
- GENC $113,116,000.00
- OBIO $2,638,000.00
- Revenue This Year
- GENC N/A
- OBIO $27.37
- Revenue Next Year
- GENC N/A
- OBIO $42.68
- P/E Ratio
- GENC $10.44
- OBIO N/A
- Revenue Growth
- GENC 5.44
- OBIO N/A
- 52 Week Low
- GENC $10.80
- OBIO $2.49
- 52 Week High
- GENC $24.88
- OBIO $8.87
- Technical
- Relative Strength Index (RSI)
- GENC 43.40
- OBIO 36.86
- Support Level
- GENC $11.12
- OBIO $2.75
- Resistance Level
- GENC $11.97
- OBIO $3.26
- Average True Range (ATR)
- GENC 0.65
- OBIO 0.48
- MACD
- GENC -0.00
- OBIO -0.01
- Stochastic Oscillator
- GENC 50.34
- OBIO 16.82
About GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.